%0 Journal Article
%T Prediction of prostate cancer aggressiveness using magnetic resonance imaging radiomics: a dual-center study.
%A Pan N
%A Shi L
%A He D
%A Zhao J
%A Xiong L
%A Ma L
%A Li J
%A Ai K
%A Zhao L
%A Huang G
%J Discov Oncol
%V 15
%N 1
%D 2024 Apr 16
%M 38625419
暂无%R 10.1007/s12672-024-00980-8
%X <B>OBJECTIVE: </B>The Gleason score (GS) and positive needles are crucial aggressive indicators of prostate cancer (PCa). This study aimed to investigate the usefulness of magnetic resonance imaging (MRI) radiomics models in predicting GS and positive needles of systematic biopsy in PCa.<BR><B>METHODS: </B>A total of 218 patients with pathologically proven PCa were retrospectively recruited from 2 centers. Small-field-of-view high-resolution T2-weighted imaging and post-contrast delayed sequences were selected to extract radiomics features. Then, analysis of variance and recursive feature elimination were applied to remove redundant features. Radiomics models for predicting GS and positive needles were constructed based on MRI and various classifiers, including support vector machine, linear discriminant analysis, logistic regression (LR), and LR using the least absolute shrinkage and selection operator. The models were evaluated with the area under the curve (AUC) of the receiver-operating characteristic.<BR><B>RESULTS: </B>The 11 features were chosen as the primary feature subset for the GS prediction, whereas the 5 features were chosen for positive needle prediction. LR was chosen as classifier to construct the radiomics models. For GS prediction, the AUC of the radiomics models was 0.811, 0.814, and 0.717 in the training, internal validation, and external validation sets, respectively. For positive needle prediction, the AUC was 0.806, 0.811, and 0.791 in the training, internal validation, and external validation sets, respectively.<BR><B>CONCLUSIONS: </B>MRI radiomics models are suitable for predicting GS and positive needles of systematic biopsy in PCa. The models can be used to identify aggressive PCa using a noninvasive, repeatable, and accurate diagnostic method.